{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:21:07Z","timestamp":1778822467960,"version":"3.51.4"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1988,4,1]],"date-time":"1988-04-01T00:00:00Z","timestamp":575856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Toxicology"],"published-print":{"date-parts":[[1988,4]]},"DOI":"10.1007\/bf03259935","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T10:14:51Z","timestamp":1354270491000},"page":"85-106","source":"Crossref","is-referenced-by-count":87,"title":["Valproate-Associated Hepatotoxicity and its Biochemical Mechanisms"],"prefix":"10.1007","volume":"3","author":[{"given":"M. J.","family":"Eadie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. D.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. G.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"BF03259935_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","volume":"40","author":"FS Abbott","year":"1986","unstructured":"Abbott FS, Kassam J, Orr JM, Farrell K. The effect of aspirin on valproic acid metabolism. Clinical Pharmacology and Therapeutics 40: 94\u2013110, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259935_CR2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-2275(20)34305-4","volume":"26","author":"A Acheampong","year":"1985","unstructured":"Acheampong A, Abbott FS. Synthesis and stereochemical determination of diunsaturated valproic acid analogs including its major diunsaturated metabolite. Journal of Lipid Research 26: 1002\u20131008, 1985","journal-title":"Journal of Lipid Research"},{"key":"BF03259935_CR3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1542\/peds.65.6.1194a","volume":"65","author":"RJ Allen","year":"1980","unstructured":"Allen RJ, Coulter DL. Valproic acid induced pancreatitis in children. Pediatrics 65: 1194\u20131195, 1980","journal-title":"Pediatrics"},{"key":"BF03259935_CR4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1542\/peds.64.4.520","volume":"64","author":"PB Batalden","year":"1979","unstructured":"Batalden PB, Van Dyne BJ, Lloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 64: 520\u2013522, 1979","journal-title":"Pediatrics"},{"key":"BF03259935_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"C-M Becker","year":"1983","unstructured":"Becker C-M, Harris RA. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Archives of Biochemistry and Biophysics 223: 381\u2013392, 1983","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"BF03259935_CR6","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/0006-2952(82)90392-6","volume":"31","author":"J Benavides","year":"1982","unstructured":"Benavides J, Martin A, Ugarte M, Valdivieso F. Inhibition by valproic acid of pyruvate uptake by brain mitochondria. Biochemical Pharmacology 31: 1633\u20131636, 1982","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-291X(85)91014-9","volume":"132","author":"SM Bjorge","year":"1985","unstructured":"Bjorge SM, Baillie TA. Inhibition of medium-chain fatty acid \u03b2-oxidation in vitroby valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochemical and Biophysical Research Communications 132: 245\u2013252, 1985","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259935_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01377353","volume":"139","author":"H B\u00f6hles","year":"1982","unstructured":"B\u00f6hles H, Richter K, Wagner-Thiessen E, Sch\u00e4fer H. Decreased serum carnitine in valproate-induced Reye syndrome. European Journal of Paediatrics 139: 185\u2013186, 1982","journal-title":"European Journal of Paediatrics"},{"key":"BF03259935_CR9","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(79)91885-3","volume":"1","author":"PR Camfield","year":"1979","unstructured":"Camfield PR, Bagnell P, Camfield CS, Tibbies JAR. Pancreatitis due to valproic acid. Lancet 1: 1198\u20131199, 1979","journal-title":"Lancet"},{"key":"BF03259935_CR10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0301-0082(82)90010-7","volume":"19","author":"A Chapman","year":"1982","unstructured":"Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC. Mechanism of anticonvulsant action of valproate. Progress in Neurobiology 19: 315\u2013359, 1982","journal-title":"Progress in Neurobiology"},{"key":"BF03259935_CR11","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(83)80205-8","volume":"115","author":"FX Coude","year":"1983","unstructured":"Coude FX, Grimber G, Pelet A, Benoit Y. Action of the anti-epileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochemical and Biophysical Research Communications 115: 730\u2013736, 1983","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259935_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(84)92209-8","volume":"1","author":"DL Coulter","year":"1984","unstructured":"Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity. Lancet 1: 689, 1984","journal-title":"Lancet"},{"key":"BF03259935_CR13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(80)91773-0","volume":"1","author":"DL Coulter","year":"1980","unstructured":"Coulter DL, Allen RJ. Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy. Lancet 1: 1310\u20131311, 1980","journal-title":"Lancet"},{"key":"BF03259935_CR14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(81)80489-1","volume":"99","author":"DL Coulter","year":"1981","unstructured":"Coulter DL, Allen RJ. Hyperammonemia with valproic acid therapy. Journal of Pediatrics 99: 317\u2013319, 1981","journal-title":"Journal of Pediatrics"},{"key":"BF03259935_CR15","first-page":"79","volume":"21","author":"RG Dickinson","year":"1985","unstructured":"Dickinson RG, Bassett ML, Searle J, Tyrer JH, Eadie MJ. Valproate hepatotoxicity: a review and report of two instances in adults. Clinical and Experimental Neurology 21: 79\u201391, 1985a","journal-title":"Clinical and Experimental Neurology"},{"key":"BF03259935_CR16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)31879-3","volume":"211","author":"RG Dickinson","year":"1979","unstructured":"Dickinson RG, Harland RC, Ilias AM, Rodgers RM, et al. Disposition of valproic acid in the rat: dose-dependent metabolism, distribution, enterohepatic recirculation and choleretic effect. Journal of Pharmacology and Experimental Therapeutics 211: 583\u2013595, 1979","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"BF03259935_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0090-9556(25)07712-8","volume":"12","author":"RG Dickinson","year":"1984","unstructured":"Dickinson RG, Hooper WD, Eadie MJ. pH-Dependent rearrangement of the biosynthetic ester glucuronide of yalproic acid to \u03b2-glucuronidase-resistant forms. Drug Metabolism and Disposition 12: 247\u2013252, 1984","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259935_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1528-1157.1985.tb05696.x","volume":"26","author":"RG Dickinson","year":"1985","unstructured":"Dickinson RG, Kluck RM, Hooper WD, Patterson M, Chalk JB, et al. Rearrangement of valproate glucuronide in a patient with drug-associated hepatobiliary and renal dysfunction. Epilepsia 26: 589\u2013593, 1985b","journal-title":"Epilepsia"},{"key":"BF03259935_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","volume":"37","author":"FE Dreifuss","year":"1987","unstructured":"Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline KA, et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 37: 379\u2013385, 1987","journal-title":"Neurology"},{"key":"BF03259935_CR20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1528-1157.1977.tb04465.x","volume":"18","author":"B Ferrandes","year":"1977","unstructured":"Ferrandes B, Eymard P. Metabolism of valproate sodium in rabbit, rat, dog and man. Epilepsia 18: 169\u2013182, 1977","journal-title":"Epilepsia"},{"key":"BF03259935_CR21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1528-1157.1981.tb04145.x","volume":"22","author":"H Gastaut","year":"1981","unstructured":"Gastaut H, Noel P. A case of fatal toxic hepatitis: recommendations for the administration of sodium valproate. Epilepsia 22: 711\u2013713, 1981","journal-title":"Epilepsia"},{"key":"BF03259935_CR22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(79)80110-9","volume":"95","author":"N Gerber","year":"1979","unstructured":"Gerber N, Dickinson RG, Harland RC, Lynn RK, Houghton D, et al. Reye like syndrome associated with valproic acid therapy. Journal of Pediatrics 95: 142\u2013144, 1979","journal-title":"Journal of Pediatrics"},{"key":"BF03259935_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1203\/00006450-197503000-00005","volume":"9","author":"AM Glasgow","year":"1975","unstructured":"Glasgow AM, Chase HP. Production of the features of Reye\u2019s syndrome in rats with 4-pentenoic acid. Pediatric Research 9: 133\u2013138, 1975","journal-title":"Pediatric Research"},{"key":"BF03259935_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0009-8981(77)90216-9","volume":"74","author":"D Gompertz","year":"1977","unstructured":"Gompertz D, Tippett P, Bartlett K, Baillie T. Identification of urinary metabolites of sodium dipropylacetate in man: potential sources of interference in organic acid screening procedures. Clinica Chimica Acta 74: 153\u2013160, 1977","journal-title":"Clinica Chimica Acta"},{"key":"BF03259935_CR25","first-page":"69","volume-title":"Chronic toxicity of antiepileptic drugs","author":"L Gram","year":"1983","unstructured":"Gram L. Hepatic toxicity of valproate: reflections on the pathogenesis and proposal for an international collaborative registration. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 69\u201378, Raven Press, New York, 1983"},{"key":"BF03259935_CR26","first-page":"97","volume-title":"Metabolism of antiepileptic drugs","author":"GR Granneman","year":"1984","unstructured":"Granneman GR, Marriott TB, Wang SI, Sennello LT, Hagen NS, et al. Aspects of the dose-dependent metabolism of valproic acid. In Levy et al. (Eds) Metabolism of antiepileptic drugs, pp. 97\u2013104, Raven Press, New York, 1984a"},{"key":"BF03259935_CR27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.1840040610","volume":"4","author":"GR Granneman","year":"1984","unstructured":"Granneman GR, Wang S-I, Kesterson JW, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats, II: intermediary and valproic acid metabolism. Hepatology 4: 1153\u20131158, 1984b","journal-title":"Hepatology"},{"key":"BF03259935_CR28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00498258409151426","volume":"14","author":"GR Granneman","year":"1984","unstructured":"Granneman GR, Wang SI, Machinist JM, Kesterson JW. Aspects of the metabolism of valproic acid. Xenobiotica 14: 375\u2013387, 1984c","journal-title":"Xenobiotica"},{"key":"BF03259935_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","volume":"5","author":"R Gugler","year":"1980","unstructured":"Gugler R, von Unruh GE. Clinical pharmacokinetics of valproic acid. Clinical Pharmacokinetics 5: 67\u201383, 1980","journal-title":"Clinical Pharmacokinetics"},{"key":"BF03259935_CR30","first-page":"420","volume":"30","author":"R Haas","year":"1980","unstructured":"Haas R, Stumpf DA, Bergen BJ, Parks JK, Eguren L. Inhibition of oxidative phosphorylation by sodium valproate. Neurology 30: 420, 1980","journal-title":"Neurology"},{"key":"BF03259935_CR31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.31.11.1473","volume":"31","author":"R Haas","year":"1981","unstructured":"Haas R, Stumpf DA, Parks JK, Eguren L. Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31: 1473\u20131476, 1981","journal-title":"Neurology"},{"key":"BF03259935_CR32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007691-198612000-00004","volume":"8","author":"D Haidukewych","year":"1986","unstructured":"Haidukewych D, John G. Chronic valproic acid and coepileptic drug therapy and incidence of increases in serum liver enzymes. Therapeutic Drug Monitoring 8: 407\u2013410, 1986","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259935_CR33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.36.3.351","volume":"36","author":"K Hayasaka","year":"1986","unstructured":"Hayasaka K, Takahashi I, Kobayashi Y, Iinuma K, Narisawa K, et al. Effects of valproate on biogenesis and function of liver mitochondria. Neurology 36: 351\u2013356, 1986","journal-title":"Neurology"},{"key":"BF03259935_CR34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0006-2952(85)90111-X","volume":"34","author":"G Heinemeyer","year":"1985","unstructured":"Heinemeyer G, Nau H, Hildebrand AG, Roots I. Oxidation and glucuronidation of valproic acid in male rats \u2014 influence of phenobarbital, 3-methylcholanthrene, \u03b2-naphthoflavone and clofibrate. Biochemical Pharmacology 34: 133\u2013139, 1985","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.292.6512.23","volume":"292","author":"M Hjelm","year":"1986","unstructured":"Hjelm M, De Silva LVK, Seakins JWT, Oberholzer VG, Rolles CJ. Evidence of inherited urea cycle defect in a case of fatal valproate toxicity. British Medical Journal 292: 23\u201324, 1986a","journal-title":"British Medical Journal"},{"key":"BF03259935_CR36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(86)92889-8","volume":"2","author":"M Hjelm","year":"1986","unstructured":"Hjelm M, Oberholzer V, Seakins J, Thomas S, Kay JDS. Valproate-induced inhibition of urea synthesis and hyperammonaemia in healthy subjects. Lancet 2: 859, 1986b","journal-title":"Lancet"},{"key":"BF03259935_CR37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-2952(85)90670-7","volume":"34","author":"S Horie","year":"1985","unstructured":"Horie S, Suga T. Enhancement of peroxisomal \u03b2-oxidation in the liver of rats and mice treated with valproic acid. Biochemical Pharmacology 34: 1357\u20131362, 1985","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR38","first-page":"901","volume":"138","author":"JB Isom","year":"1984","unstructured":"Isom JB. On the toxicity of valproic acid. American Journal of Diseases of Children 138: 901\u2013903, 1984","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259935_CR39","first-page":"178","volume":"6","author":"JB Isom","year":"1979","unstructured":"Isom JB, Gerber N, Lynn RK, Harland RC, Kaufman SN, et al. Pharmacokinetic studies of valproic acid: serum half-life and tissue distribution in 2 children dying in acute hepatic failure. Annals of Neurology 6: 178, 1979","journal-title":"Annals of Neurology"},{"key":"BF03259935_CR40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1528-1157.1978.tb05039.x","volume":"19","author":"C Jakobs","year":"1978","unstructured":"Jakobs C, Loscher W. Identification of metabolites of valproic acid in serum of humans, dog, rat and mouse. Epilepsia 19: 591\u2013602, 1978","journal-title":"Epilepsia"},{"key":"BF03259935_CR41","first-page":"1","volume-title":"Chronic toxicity of antiepileptic drugs","author":"PM Jeavons","year":"1983","unstructured":"Jeavons PM. Hepatotoxicity of antiepileptic drugs. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, pp. 1\u201345, Raven Press, New York, 1983"},{"issue":"1","key":"BF03259935_CR42","first-page":"S5O","volume":"25","author":"PM Jeavons","year":"1984","unstructured":"Jeavons PM. Non-dose-related side effects of valproate. Epilepsia 25 (Suppl. 1): S5O\u2013S55, 1984","journal-title":"Epilepsia"},{"key":"BF03259935_CR43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.0954-6820.1983.tb03759.x","volume":"213","author":"RL Karlsen","year":"1983","unstructured":"Karlsen RL, Kett K, Henriksen OE. Intoxication with sodium valproate. Acta Medica Scandinavica 213: 405\u2013406, 1983","journal-title":"Acta Medica Scandinavica"},{"key":"BF03259935_CR44","first-page":"1283","volume":"2","author":"JDS Kay","year":"1986","unstructured":"Kay JDS, Hilton-Jones D, Hyman N. Valproate toxicity and ornithine carbamoyltransferase deficiency. Lancet 2: 1283\u20131284, 1986","journal-title":"Lancet"},{"key":"BF03259935_CR45","volume-title":"Chronic toxicity of antiepileptic drugs","author":"D Keene","year":"1983","unstructured":"Keene D, Humphreys P, Carpenter B, Reicher J. Poster presentation at Epilepsy International Congress, Kyoto, 1981. Cited by Jeavons PM. Hepatotoxicity of antiepileptic drugs. In Oxley et al. (Eds) Chronic toxicity of antiepileptic drugs, Raven Press, New York, 1983"},{"key":"BF03259935_CR46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0306-3623(81)90101-4","volume":"12","author":"RW Kerwin","year":"1981","unstructured":"Kerwin RW, Taberner PV. The mechanism of action of sodium valproate. General Pharmacology 12: 71\u201375, 1981","journal-title":"General Pharmacology"},{"key":"BF03259935_CR47","first-page":"1143","volume":"4","author":"JW Kesterson","year":"1984","unstructured":"Kesterson JW, Granneman GR, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologie, biochemical and histopathologic studies. Hepatology 4: 1143\u20131152, 1984","journal-title":"I. Toxicologie, biochemical and histopathologic studies. Hepatology"},{"key":"BF03259935_CR48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2008-1034017","volume":"197","author":"FP Keulen","year":"1985","unstructured":"Keulen FP, Kochen W. Hepatotoxizitat unter Valproinsaure behandlung. Klinische P\u00e4diatrie 197: 431\u2013436, 1985","journal-title":"Klinische P\u00e4diatrie"},{"key":"BF03259935_CR49","first-page":"1090","volume":"27","author":"W Kochen","year":"1977","unstructured":"Kochen W, Imbeck H, Jakobs C. Untersuchungen uber die Ausscheidung von Metaboliten de Valproinsaure in Urin der Ratte und das Menschen. Arzneimittel Forschung 27: 1090\u20131099, 1977","journal-title":"Arzneimittel Forschung"},{"key":"BF03259935_CR50","first-page":"111","volume-title":"Antiepileptic therapy: advances in drug monitoring","author":"W Kochen","year":"1980","unstructured":"Kochen W, Scheffner H. On unsaturated metabolites of the valproic acid (VPA) in serum of epileptic children. In Johannessen et al. (Eds) Antiepileptic therapy: advances in drug monitoring, pp. 111\u2013120, Raven Press, New York, 1980"},{"key":"BF03259935_CR51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00445664","volume":"141","author":"W Kochen","year":"1983","unstructured":"Kochen W, Schneider A, Ritz A. Abnormal metabolism of valproic acid in fatal hepatic failure. European Journal of Pediatrics 141: 30\u201335, 1983","journal-title":"European Journal of Pediatrics"},{"key":"BF03259935_CR52","first-page":"309","volume":"22","author":"W Kochen","year":"1984","unstructured":"Kochen W, Sprunck HP, Tauscher B, Klemens M. Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on valproic acid therapy. Journal of Clinical Chemistry and Clinical Biochemistry 22: 309\u2013317, 1984","journal-title":"Journal of Clinical Chemistry and Clinical Biochemistry"},{"key":"BF03259935_CR53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0003-9861(79)90535-6","volume":"198","author":"H Kochi","year":"1979","unstructured":"Kochi H, Hayasaka K, Hiraga K, Kikuchi G. Reduction of the level of the glycine cleavage system in the rat liver resulting from administration of dipropylacetic acid: an experimental approach to hyperglycinemia. Archives of Biochemistry and Biophysics 198: 589\u2013597, 1979","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"BF03259935_CR54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF03189503","volume":"3","author":"T Kuhara","year":"1978","unstructured":"Kuhara T, Hirakata Y, Yamada S, Matsumoto I. Metabolism of sodium dipropylacetate in humans. European Journal of Drug Metabolism and Pharmacokinetics 3: 171\u2013177, 1978","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"BF03259935_CR55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0009-8981(85)90280-3","volume":"145","author":"T Kuhara","year":"1985","unstructured":"Kuhara T, Inoue Y, Matsumoto M, Shinka T, Matsumoto I, et al. Altered metabolic profiles of valproic acid in a patient with Reye\u2019s syndrome. Clinica Chimica Acta 145: 135\u2013142, 1985","journal-title":"Clinica Chimica Acta"},{"key":"BF03259935_CR56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bms.1200010415","volume":"1","author":"T Kuhara","year":"1974","unstructured":"Kuhara T, Matsumoto I. Metabolism of branched medium chain length fatty acid, I: w-oxidation of sodium dipropylacetate in rats. Biomedical Mass Spectrometry 1: 291\u2013294, 1974","journal-title":"Biomedical Mass Spectrometry"},{"key":"BF03259935_CR57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1528-1157.1986.tb03501.x","volume":"27","author":"MC Laub","year":"1986","unstructured":"Laub MC. Nutritional influence of serum ammonia in young patients receiving sodium valproate. Epilepsia 27: 55\u201359, 1986","journal-title":"Epilepsia"},{"key":"BF03259935_CR58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1157.1986.tb03584.x","volume":"27","author":"MC Laub","year":"1986","unstructured":"Laub MC, Paetzke-Brunner I, Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 27: 559\u2013562, 1986","journal-title":"Epilepsia"},{"key":"BF03259935_CR59","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840020622","volume":"2","author":"JH Lewis","year":"1982","unstructured":"Lewis JH, Zimmerman HJ, Garrett CT, Rosenberg E. Valproate-induced hepatic steatogenesis in rats. Hepatology 2: 870\u2013873, 1982","journal-title":"Hepatology"},{"key":"BF03259935_CR60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1528-1157.1981.tb04098.x","volume":"22","author":"W Loscher","year":"1981","unstructured":"Loscher W. Concentration of metabolites of valproic acid in plasma of epileptic patients. Epilepsia 22: 169\u2013178, 1981","journal-title":"Epilepsia"},{"key":"BF03259935_CR61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0028-3908(81)90062-9","volume":"20","author":"W Loscher","year":"1981","unstructured":"Loscher W, Bohme G, Schafer H, Kochen W. Effect of metabolites of valproic acid on the metabolism of G ABA in brain and brain nerve endings. Neuropharmacology 20: 1187\u20131192, 1981","journal-title":"Neuropharmacology"},{"key":"BF03259935_CR62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1528-1157.1980.tb04314.x","volume":"21","author":"W Loscher","year":"1980","unstructured":"Loscher W, Schmidt D. Increase of human plasma GABA by sodium valproate. Epilepsia 21: 611\u2013615, 1980","journal-title":"Epilepsia"},{"key":"BF03259935_CR63","first-page":"2877","volume":"16","author":"A Martin-Gallardo","year":"1983","unstructured":"Martin-Gallardo A, Rodriguez P, Lopez M, Benavides J, Ugarte M. Effect of dipropylacetate on the glycine cleavage enzyme system and glycine levels: a possible experimental approach to non-ketotic hyperglycinemia. Biochemical Pharmacology 16: 2877\u20132882, 1983","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR64","unstructured":"Matsumoto I, Kuhara T, Inoue Y, Matsumoto M, Ohkura T. Differential diagnosis for hepatopathy in five patients with valproate therapy. Proceedings of the 34th Annual Conference on Mass Spectrometry and Allied Topics, June 8\u201313, 1986, Cincinnati, Ohio, pp. 925\u2013926, 1986"},{"key":"BF03259935_CR65","first-page":"169","volume-title":"Metabolism of antiepileptic drugs","author":"I Matsumoto","year":"1984","unstructured":"Matsumoto I, Kuhara T, Shinka T, Inoue Y, Matsumoto M. Effect of valproic acid on amino acid and organic acid metabolism. In Levy et al. (Eds) Metabolism of antiepileptic drugs, pp. 169\u2013174, Raven Press, New York, 1984"},{"key":"BF03259935_CR66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/bms.1200030509","volume":"3","author":"I Matsumoto","year":"1976","unstructured":"Matsumoto I, Kuhara T, Yoshino M. Metabolism of branched chain medium length fatty acid II: \u03b2-oxidation of sodium dipropylacetate in rats. Biomedical Mass Spectrometry 3: 235\u2013240, 1976a","journal-title":"Biomedical Mass Spectrometry"},{"key":"BF03259935_CR67","first-page":"17","volume":"1","author":"I Matsumoto","year":"1976","unstructured":"Matsumoto I, Kuhara T, Yoshino M. The effect of isoleucine on the metabolism of sodium dipropylacetate in rats. Advances in Mass Spectrometry in Biochemistry and Medicine 1: 17\u201326, 1976b","journal-title":"Advances in Mass Spectrometry in Biochemistry and Medicine"},{"key":"BF03259935_CR68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(85)90020-8","volume":"145","author":"DS Millington","year":"1985","unstructured":"Millington DS, Bohan TP, Roe CP, Yergey AL, Liberato DJ. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. Clinica Chimica Acta 145: 69\u201376, 1985","journal-title":"Clinica Chimica Acta"},{"key":"BF03259935_CR69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(84)92139-1","volume":"1","author":"JR Moore","year":"1984","unstructured":"Moore JR, Williams THC, Talbot IC, Tanner MS. Heterozygous \u03b11-antitrypsin deficiency and valproate hepatotoxicity. Lancet 1: 221, 1984","journal-title":"Lancet"},{"key":"BF03259935_CR70","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0140-6736(80)90197-X","volume":"2","author":"PB Mortensen","year":"1980","unstructured":"Mortensen PB. Inhibition of fatty acid oxidation by valproate. Lancet 2: 856\u2013857, 1980","journal-title":"Lancet"},{"key":"BF03259935_CR71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0006-2944(80)90006-X","volume":"24","author":"PB Mortensen","year":"1980","unstructured":"Mortensen PB, Gregersen N, Kocvraa S, Christensen E. The occurrence of C6-C10-dicarboxylic acids in urine from patients and rats treated with dipropylacetate. Biochemical Medicine 24: 153\u2013161, 1980a","journal-title":"Biochemical Medicine"},{"key":"BF03259935_CR72","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1528-1157.1980.tb04310.x","volume":"21","author":"PB Mortensen","year":"1980","unstructured":"Mortensen PB, Kolvraa S, Christensen E. Inhibition of the glycine cleavage system: hyperglycinemia and hyperglycinuria caused by valproic acid. Epilepsia 21: 563\u2013569, 1980b","journal-title":"Epilepsia"},{"key":"BF03259935_CR73","first-page":"85","volume-title":"Metabolism of antiepileptic drugs","author":"H Nau","year":"1984","unstructured":"Nau H, Merker H-J, Brendel K, Gansan C, Hauser I, et al. Disposition, embryotoxicity and teratogenicity of valproic acid in the mouse as related to man. In Levy et al. (Eds) Metabolism of antiepileptic drugs, pp. 85\u201393, Raven Press, New York, 1984"},{"issue":"1","key":"BF03259935_CR74","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1528-1157.1984.tb05632.x","volume":"25","author":"H Nau","year":"1984","unstructured":"Nau H, Loscher W. Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia 25 (Suppl. 1): S14\u2013S22, 1984","journal-title":"Epilepsia"},{"key":"BF03259935_CR75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-4347(00)84207-3","volume":"226","author":"H Nau","year":"1981","unstructured":"Nau H, Wittfoht W, Schafer H, Jakobs C, Rating D, et al. Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissue by gas chromatographymass spectrometry using selected ion monitoring. Journal of Chromatography 226: 69\u201378, 1981","journal-title":"Journal of Chromatography"},{"key":"BF03259935_CR76","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","volume":"101","author":"Y Ohtani","year":"1982","unstructured":"Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyper-ammonemia associated with valproic acid therapy. Journal of Pediatrics 101: 782\u2013785, 1982","journal-title":"Journal of Pediatrics"},{"key":"BF03259935_CR77","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/clpt.1982.89","volume":"31","author":"JM Orr","year":"1982","unstructured":"Orr JM, Abbott FS, Farrell K, Ferguson S, Sheppard I, et al. Interaction between valproic acid and aspirin in epileptic children: serum protein binding and metabolic effects. Clinical Pharmacology and Therapeutics 31: 642\u2013649, 1982","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259935_CR78","first-page":"591","volume":"27","author":"S Panesar","year":"1986","unstructured":"Panesar S, Orr J, Burton R, Farrell K. Effect of carbamazepine on valproic acid metabolism. Epilepsia 27: 591, 1986","journal-title":"Epilepsia"},{"key":"BF03259935_CR79","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","volume":"25","author":"PR Powell-Jackson","year":"1984","unstructured":"Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut 25: 673\u2013681, 1984","journal-title":"Gut"},{"key":"BF03259935_CR80","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/0006-291X(84)91214-2","volume":"122","author":"KS Prickett","year":"1984","unstructured":"Prickett KS, Baillie TA. Metabolism of valproic acid by hepatic microsomal cytochrome P450. Biochemical and Biophysical Research Communications 122: 1166\u20131173, 1984","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259935_CR81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0090-9556(25)08326-6","volume":"14","author":"KS Prickett","year":"1986","unstructured":"Prickett KS, Baillie TA. Metabolism of unsaturated derivatives of valproic acid in rat liver microsomes and destruction of cytochrome P-450. Drug Metabolism and Disposition 14: 221\u2013229, 1986","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259935_CR82","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.31.9.1173","volume":"31","author":"S Rawat","year":"1981","unstructured":"Rawat S, Borkowski WJ, Swick HM. Valproic acid and secondary hyperammonemia. Neurology 31: 1173\u20131174, 1981","journal-title":"Neurology"},{"key":"BF03259935_CR83","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0090-9556(25)08858-0","volume":"14","author":"AW Rettenmeier","year":"1986","unstructured":"Rettenmeier AW, Gordon WP, Prickett KS, Levy RH, Baillie TA. Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid. Drug Metabolism and Disposition 14: 454\u2013464, 1986a","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259935_CR84","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0090-9556(25)08857-9","volume":"14","author":"AW Rettenmeier","year":"1986","unstructured":"Rettenmeier AW, Gordon WP, Prickett KS, Levy RH, Lockard JS, et al. Metabolic fate of valproic acid in the rhesus monkey: formation on a toxic metabolite, 2-n-propyl-4-pentenoic acid. Drug Metabolism and Disposition 14: 443\u2013453, 1986b","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259935_CR85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0090-9556(25)07823-7","volume":"15","author":"AW Rettenmeier","year":"1985","unstructured":"Rettenmeier AW, Prickett KS, Gordon WP, Bjorge SM, Chang S-L, et al. Studies on the biotransformation in the perfused rat liver on 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Drug Metabolism and Disposition 15: 81\u201396, 1985","journal-title":"Drug Metabolism and Disposition"},{"key":"BF03259935_CR86","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/clpt.1986.160","volume":"40","author":"AE Rettie","year":"1986","unstructured":"Rettie AE, Rettenmeier AW, Bayer BK, Baillie TA, Juchau MR. Valproate hydroxylation by human fetal tissues and embryotoxicity of metabolites. Clinical Pharmacology and Therapeutics 40: 172\u2013177, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259935_CR87","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.3101178","volume":"235","author":"AE Rettie","year":"1987","unstructured":"Rettie AE, Rettenmeier AW, Howald WN, Baillie TA. Cytochrome P-450-catalysed formation of \u03944-VPA, a toxic metabolite of valproic acid. Science 235: 890\u2013893, 1987","journal-title":"Science"},{"key":"BF03259935_CR88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/00498258509047438","volume":"15","author":"A Rogiers","year":"1985","unstructured":"Rogiers A, Vandenberghe Y, Vercruysse A. Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytes. Xenobiotica 15: 759\u2013765, 1985","journal-title":"Xenobiotica"},{"key":"BF03259935_CR89","first-page":"474","volume-title":"The metabolic basis of inherited disease","author":"E Rosenberg","year":"1983","unstructured":"Rosenberg E. Disorders of propionate and methylmalonate metabolism. In Stanbury et al. (Eds) The metabolic basis of inherited disease, 5th ed., pp. 474\u2013497, McGraw-Hill, New York, 1983","edition":"5th"},{"key":"BF03259935_CR90","first-page":"287","volume":"10","author":"AD Rothner","year":"1981","unstructured":"Rothner AD. Valproic acid: a review of 23 fatal cases. Annals of Neurology 10: 287, 1981","journal-title":"Annals of Neurology"},{"key":"BF03259935_CR91","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0022-510X(83)90174-0","volume":"61","author":"L Rumbach","year":"1983","unstructured":"Rumbach L, Warter JM, Rendon A, Marescaux C, Micheletti G, et al. Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. Journal of the Neurological Sciences 61: 417\u2013423, 1983","journal-title":"Journal of the Neurological Sciences"},{"key":"BF03259935_CR92","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1528-1157.1975.tb04747.x","volume":"16","author":"MCB Sawaya","year":"1975","unstructured":"Sawaya MCB, Horton RW, Meldrum BS. Effects of anticonvulsant drugs on the cerebral enzymes metabolising GABA. Epilepsia 16: 649\u2013655, 1975","journal-title":"Epilepsia"},{"key":"BF03259935_CR93","first-page":"657","volume":"28","author":"H Schafer","year":"1978","unstructured":"Schafer H, Luhrs R. Gas Chromatographie determination of the valproic acid metabolite artifacts, heptanone-3, 4- and 5-hydroxyvalproic acid lactone. Arzneimittel-Forschung 28: 657\u2013662, 1978","journal-title":"Arzneimittel-Forschung"},{"key":"BF03259935_CR94","first-page":"73","volume-title":"Metabolism of antiepileptic drugs","author":"H Schafer","year":"1984","unstructured":"Schafer H, Luhrs R. Responsibility of the metabolic pattern for potential side-effects in the rat being treated with valproic acid, 2-propylpenten-2-oic acid, and 2-propylpenten-4-oic acid. In Levy et al. (Eds) Metabolism of antiepileptic drugs, pp. 73\u201381, Raven Press, New York, 1984a"},{"key":"BF03259935_CR95","unstructured":"Schafer H, Luhrs R. Determination of 4,5-dihydroxy valproate, a target molecule in a potentially pathological valproate metabolism. Ninth European Workshop on Drug Metabolism, Pont-a-Mousson, 1984b"},{"key":"BF03259935_CR96","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0140-6736(86)90376-4","volume":"2","author":"D Scheffner","year":"1986","unstructured":"Scheffner D. Fatal liver failure in children on valproate. Lancet 2: 511, 1986","journal-title":"Lancet"},{"key":"BF03259935_CR97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(77)90385-0","volume":"74","author":"RD Schmid","year":"1977","unstructured":"Schmid RD. Propionic acid and dipropylacetic acid in the urine of patients treated with dipropylacetic acid. Clinica Chimica Acta 74: 39\u201342, 1977","journal-title":"Clinica Chimica Acta"},{"key":"BF03259935_CR98","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(84)92140-8","volume":"1","author":"R Schnabel","year":"1984","unstructured":"Schnabel R, Rambeck B, Janssen F. Fatal intoxication with sodium valproate. Lancet 1: 221\u2013222, 1984","journal-title":"Lancet"},{"key":"BF03259935_CR99","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0006-2952(76)90139-8","volume":"25","author":"HSA Sherratt","year":"1976","unstructured":"Sherratt HSA, Osmundsen H. On the mechanisms of some pharmacological actions of the hypoglycemic toxins hypoglycin and pent-4-enoic acid: a way out of the confusion. Biochemical Pharmacology 25: 743\u2013750, 1976","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-510X(80)80009-8","volume":"45","author":"S Simila","year":"1980","unstructured":"Simila S, Von Wendt L, Linna S-L. Dipropylacetate and aminoaciduria. Journal of the Neurological Sciences 45: 83\u201386, 1980","journal-title":"Journal of the Neurological Sciences"},{"key":"BF03259935_CR101","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1528-1157.1975.tb04738.x","volume":"16","author":"D Simon","year":"1975","unstructured":"Simon D, Penry JK. Sodium di-n-propylacetate (DPA) in the treatment of epilepsy. Epilepsia 16: 549\u2013573, 1975","journal-title":"Epilepsia"},{"key":"BF03259935_CR102","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.35.7.1041","volume":"35","author":"DA Stumpf","year":"1985","unstructured":"Stumpf DA, Parker Jr WD, Angelini C. Carnitine deficiency, organic acidemias and Reye\u2019s syndrome. Neurology 35: 1041\u20131045, 1985","journal-title":"Neurology"},{"key":"BF03259935_CR103","first-page":"84","volume-title":"Drug-induced hepatic injury","author":"BHC Stricker","year":"1985","unstructured":"Stricker BHC, Spoelstra P. Drug-induced hepatic injury, pp. 84\u201387, Elsevier, Amsterdam, 1985"},{"key":"BF03259935_CR104","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1056\/NEJM197904263001706","volume":"300","author":"FJ Suchy","year":"1979","unstructured":"Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, et al. Acute hepatic failure associated with the use of sodium valproate. New England Journal of Medicine 300: 962\u2013966, 1979","journal-title":"New England Journal of Medicine"},{"key":"BF03259935_CR105","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jama.1979.03300110045025","volume":"242","author":"NM Sussman","year":"1979","unstructured":"Sussman NM, McLain LW. A direct hepatotoxic effect of valproic acid. Journal of the American Medical Association 242: 1173\u20131174, 1979","journal-title":"Journal of the American Medical Association"},{"key":"BF03259935_CR106","first-page":"440","volume-title":"The metabolic basis of inherited disease","author":"K Tanaka","year":"1983","unstructured":"Tanaka K, Rosenberg E. Disorders of branched chain amino acid and organic acid metabolism. In Stanbury et al. (Eds) The metabolic basis of inherited disease, 5th ed., pp. 440\u2013473, McGraw Hill, New York, 1983","edition":"5th"},{"key":"BF03259935_CR107","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0006-2952(84)90169-2","volume":"33","author":"WS Thayer","year":"1984","unstructured":"Thayer WS. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid \u2014 induced fatty liver: a possible model for Reye\u2019s syndrome. Biochemical Pharmacology 33: 1187\u20131194, 1984","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR108","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(81)92338-2","volume":"1","author":"JH Tripp","year":"1981","unstructured":"Tripp JH, Hargreaves T, Anthony PP, Searle JF, Miller P, et al. Sodium valproate and ornithine carboxyl transferase deficiency. Lancet 1: 1165\u20131166, 1981","journal-title":"Lancet"},{"key":"BF03259935_CR109","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","volume":"32","author":"DM Turnbull","year":"1983","unstructured":"Turnbull DM, Bone AJ, Bartlett K, Koundakjian PP, Sherratt HSA. The effect of valproate on intermediary metabolism of isolated rat hepatocytes and intact rats. Biochemical Pharmacology 32: 1887\u20131892, 1983","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.49.4.405","volume":"49","author":"DM Turnbull","year":"1986","unstructured":"Turnbull DM, Dick DJ, Wilson L, Sherratt HSA, Alberti KGMM. Valproate causes metabolic disturbance in normal man. Journal of Neurology, Neurosurgery and Psychiatry 49: 405\u2013410, 1986","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"BF03259935_CR111","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0006-2952(85)90409-5","volume":"34","author":"C Branden Van der","year":"1985","unstructured":"Van der Branden C, Roels F. Perioxisomal \u03b2-oxidation and sodium valproate. Biochemical Pharmacology 34: 2147\u20132149, 1985","journal-title":"Biochemical Pharmacology"},{"key":"BF03259935_CR112","first-page":"290","volume":"112","author":"TB Vree","year":"1977","unstructured":"Vree TB, van der Kleijn E. Pharmacokinetics and renal excretion of 2-n-propyl pentanoate (Depakine) in man, dog and Rhesus monkey. Pharmaceutisch Weekblad 112: 290\u2013292, 1977","journal-title":"Pharmaceutisch Weekblad"},{"key":"BF03259935_CR113","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.33.9.1136","volume":"33","author":"JM Warter","year":"1983","unstructured":"Warter JM, Brandt C, Marescaux C, Rumbach L, Micheletti G, et al. The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Neurology 33: 1136\u20131140, 1983a","journal-title":"Neurology"},{"key":"BF03259935_CR114","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(83)90327-8","volume":"87","author":"JM Warter","year":"1983","unstructured":"Warter JM, Imler M, Marescaux C, Chabrier G, Rumbach L, et al. Sodium valproate-induced hyperammonemia in the rat: role of the kidney. European Journal of Pharmacology 87: 177\u2013182, 1983b","journal-title":"European Journal of Pharmacology"},{"key":"BF03259935_CR115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1212\/WNL.34.4.550","volume":"34","author":"CA Williams","year":"1984","unstructured":"Williams CA, Tiefenbach S, McReynolds JW. Valproic acid-induced hyperammonemia in mentally retarded adults. Neurology 34: 550\u2013553, 1984","journal-title":"Neurology"},{"key":"BF03259935_CR116","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.28.9.961","volume":"28","author":"LJ Willmore","year":"1978","unstructured":"Willmore LJ, Wilder BJ, Bruni J, Villarreal, HJ. Effect of valproic acid on hepatic function. Neurology 28: 961\u2013964, 1978","journal-title":"Neurology"},{"key":"BF03259935_CR117","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1542\/peds.67.1.162","volume":"67","author":"B Wolf","year":"1981","unstructured":"Wolf B, Paulsen EP, Dreifuss FE. Valproate in the treatment of seizures associated with propionic acidemia. Pediatrics 67: 162\u2013163, 1981","journal-title":"Pediatrics"},{"key":"BF03259935_CR118","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1212\/WNL.34.11.1519","volume":"34","author":"G Zaccara","year":"1984","unstructured":"Zaccara G, Campostrini R, Paganini M, Moroni F, Valenza T, et al. Acute changes of blood ammonia may predict short-term adverse effects of valproic acid. Neurology 34: 1519\u20131521, 1984","journal-title":"Neurology"},{"key":"BF03259935_CR119","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840020520","volume":"2","author":"ES Zafrani","year":"1982","unstructured":"Zafrani ES, Berthelot P. Sodium valproate in the induction of unusual hepatotoxicity. Hepatology 2: 648\u2013649, 1982","journal-title":"Hepatology"},{"key":"BF03259935_CR120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","volume":"2","author":"HJ Zimmerman","year":"1982","unstructured":"Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2: 591\u2013597, 1982","journal-title":"Hepatology"}],"container-title":["Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259935.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259935\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:28:58Z","timestamp":1745368138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,4]]},"references-count":120,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1988,4]]}},"alternative-id":["BF03259935"],"URL":"https:\/\/doi.org\/10.1007\/bf03259935","relation":{},"ISSN":["0112-5966"],"issn-type":[{"value":"0112-5966","type":"print"}],"subject":[],"published":{"date-parts":[[1988,4]]}}}